Borg A - Search Results

1

Expression profiling to predict outcome in breast cancer: the influence of sample selection.

Gruvberger SK, Ringnér M, Edén P, Borg A, Fernö M, Peterson C, Meltzer PS. Gruvberger SK, et al. Among authors: borg a. Breast Cancer Res. 2003;5(1):23-6. doi: 10.1186/bcr548. Epub 2002 Oct 11. Breast Cancer Res. 2003. PMID: 12559041 Free PMC article.

2

Gene expression in inherited breast cancer.

Hedenfalk IA, Ringnér M, Trent JM, Borg A. Hedenfalk IA, et al. Among authors: borg a. Adv Cancer Res. 2002;84:1-34. doi: 10.1016/s0065-230x(02)84001-5. Adv Cancer Res. 2002. PMID: 11883525 Review.

3

c-myc amplification is an independent prognostic factor in postmenopausal breast cancer.

Borg A, Baldetorp B, Fernö M, Olsson H, Sigurdsson H. Borg A, et al. Int J Cancer. 1992 Jul 9;51(5):687-91. doi: 10.1002/ijc.2910510504. Int J Cancer. 1992. PMID: 1612775

4

Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.

Fernö M, Baldetorp B, Borg A, Olsson H, Sigurdsson H, Killander D. Fernö M, et al. Among authors: borg a. Acta Oncol. 1992;31(2):157-65. doi: 10.3109/02841869209088897. Acta Oncol. 1992. PMID: 1622630

5

ERBB2 amplification in breast cancer with a high rate of proliferation.

Borg A, Baldetorp B, Fernö M, Killander D, Olsson H, Sigurdsson H. Borg A, et al. Oncogene. 1991 Jan;6(1):137-43. Oncogene. 1991. PMID: 1671531

6

Early oral contraceptive use and premenopausal breast cancer--a review of studies performed in southern Sweden.

Olsson H, Borg A, Fernö M, Möller TR, Ranstam J. Olsson H, et al. Among authors: borg a. Cancer Detect Prev. 1991;15(4):265-71. Cancer Detect Prev. 1991. PMID: 1794133

7

HER-2/neu amplification predicts poor survival in node-positive breast cancer.

Borg A, Tandon AK, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Killander D, McGuire WL. Borg A, et al. Cancer Res. 1990 Jul 15;50(14):4332-7. Cancer Res. 1990. PMID: 1973070

8

Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.

Borg A, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Olsson H, Killander D, McGurie WL. Borg A, et al. Br J Cancer. 1991 Jan;63(1):136-42. doi: 10.1038/bjc.1991.28. Br J Cancer. 1991. PMID: 1989653 Free PMC article.

9

Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels.

Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Fernö M, Killander D, Olsson H, Ranstam J. Sigurdsson H, et al. Among authors: borg a. Br J Cancer. 1990 Nov;62(5):786-90. doi: 10.1038/bjc.1990.380. Br J Cancer. 1990. PMID: 2245171 Free PMC article.

10

Indicators of prognosis in node-negative breast cancer.

Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Fernö M, Killander D, Olsson H. Sigurdsson H, et al. Among authors: borg a. N Engl J Med. 1990 Apr 12;322(15):1045-53. doi: 10.1056/NEJM199004123221505. N Engl J Med. 1990. PMID: 2320064 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

856 results

Search Page

Filters